Company Search:
Advanced Search
Sponsored Links
PDL Biopharma, Inc. Company Snapshot
PDL Biopharma, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares PDL Biopharma with three other companies in this sector in the United States: ANI Pharmaceuticals Inc (2016 sales of $128.62 million of which 100% was Pharmaceutical Products), Heska Corporation ($130.08 million of which 83% was Core Companion Animal Health), and Halozyme Therapeutics, Inc. ($146.69 million of which 100% was Biopharmaceutical).

Sales Analysis. PDL Biopharma reported sales of $244.30 million for the year ending December of 2016. This represents a sharp decrease of 58.6% versus 2015, when the company's sales were $590.45 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
PDL Biopharma, Inc.
  Stock Performance Chart for PDL Biopharma, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 2.84
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks -6.3%  
4 Weeks -18.2%   52 Weeks 25.1%  
PDL Biopharma, Inc. Key Data:
  Ticker: PDLI Country: United States
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 244,301,000
(Year Ending Jan 2017).
Employees: 11
  Currency: U.S. Dollars Market Cap: 438,322,172
  Fiscal Yr Ends: December Shares Outstanding: 154,338,793
  Share Type: Common Closely Held Shares: 4,217,155
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.